Scientists are fighting for their halted funds. Trust of Black communities may be harder to win back

ABC News
Original Story by ABC News
November 22, 2026
Scientists are fighting for their halted funds. Trust of Black communities may be harder to win back

A Pittsburgh Alzheimer’s study focusing on why Black Americans are at higher risk was abruptly halted near its end after more than $8 million in taxpayer funding was pulled, undermining trust built with participants and raising concerns about broader cuts to minority-focused research. Researchers say the move, framed as not scientific, erodes momentum in understanding disparities and risks delaying potential care insights. The stoppage mirrors nationwide terminations of similarly framed projects, prompting lawsuits and ethical questions about handling collected data and samples. Critics warn that political bias, not evidence, is guiding funding decisions, with long-term implications for minority health research and community trust. The path forward remains uncertain as the administration reshapes research priorities and communities seek accountability and renewed engagement.

Dive Deeper:

  • In Pittsburgh, the study engaged Black community members in Hill and Homewood to test memory, track sleep and blood pressure, and gather personal histories to identify dementia risks; it was in its fifth and final year and near completion when funding was cut.

  • Researchers say more than $8 million had already been spent, and participants fear they will learn nothing about their brain health as a result of the abrupt shutdown, undermining years of trust built with the community.

  • Negar Fani’s similar NIH-funded project on how daily racial discrimination affects the brain was halted midstream (66 of 220 planned participants), with about $2.3 million still needed to complete, illustrating a broader pattern of terminations labeled as not scientific.

  • Several linked studies are part of a lawsuit against NIH and HHS, including Ann Cohen’s parallel work that had spent $5.2 million over three years; ethical questions have arisen about what to do with collected blood samples and data.

  • Spokespersons argue that shifting funding toward more rigorous, non-DEI focused research is a priority, but critics say this reflects political bias rather than peer-reviewed evidence, risking wasted resources and missed discoveries for minority health.

  • Analysts note a broader trend this year of fewer multiyear grants, with about 2,000 fewer awards and roughly $200 million less in multiyear funding compared with the prior year, signaling a substantial shift in research investment.